Higher levels of adiponectin, despite being lower in patients with obesity, can improve insulin sensitivity and exert anti-inflammatory properties, potentially offsetting some negative health outcomes associated with obesity [52]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.